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ABSTRACT 
 
 
 
Plasma Citrulline Levels in Horses at Risk of Acute Laminitis. (May 2013) 
 
 
Amy Lynn Jackson 
College of Veterinary Medicine and Biomedical Sciences 
Texas A&M University 
 
 
Research Advisors: Dr. Jan Janecka, Dr. Samantha Steelman 
Department of Veterinary Integrative Biosciences 
Texas A&M University 
 
 
 
Laminitis is a painful and irreversible disease in horses in which the soft tissue structures of the 
foot, called the laminae (connecting the coffin bone to the hoof wall), lose blood flow and 
deteriorate. Without the support of these laminae the coffin bone rotates downward, applying 
pressure to the sole of the foot and crushing the underlying structures, resulting in severe pain. 
Laminitis typically progresses through three stages: the early developmental stage is treatable yet 
undetectable, while the later acute and chronic stages are symptomatic but irreversible. 
Therefore, the identification of a diagnostic marker capable of detecting the developmental stage 
would allow earlier and more effective treatment.  
 
Laminitis is often triggered by unrelated events occurring elsewhere in the body such as 
gastrointestinal (GI) upset episodes, typically called “colic”, which involve intestinal epithelial 
cell death. Human studies have concluded that intestinal epithelium health can be measured 
using plasma citrulline concentrations. Citrulline is an α-amino acid circulated in the plasma that 
is produced mainly by intestinal epithelial cells. We hypothesized that horses in the 
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developmental stage of laminitis would have reduced plasma citrulline concentrations resulting 
from intestinal epithelial cell death occurring from a GI upset episode.  
 
In this study, blood samples were collected from control horses (n=23) and horses at risk for 
developing laminitis (n=20). Plasma citrulline concentration was measured using 
chromatography based amino acid analysis. The normal range was then calculated from the 
control group and compared to the concentrations from horses that did or did not develop 
laminitis. Five of the 20 cases developed laminitis symptoms and also had reduced plasma 
citrulline concentrations. If decreased citrulline levels correlate with laminitis onset across a 
large set of samples, a simple and affordable blood test could be developed in the future to 
predict the likelihood of the disease progression to the acute and chronic (irreversible) stages. 
This would allow veterinarians to begin treatments that could significantly reduce the chance of 
the horse developing the condition, greatly improving their prognosis. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 
Background 
Laminitis, the same disease that claimed the lives of the famous racehorses Secretariat and 
Barbaro, afflicts many horses worldwide at some point in their lifetime and is often career ending 
and life threatening to those afflicted (Moyer, 2004). 
 
During laminitis, the soft tissue structures called the laminae, which lie between the third 
phalanx (also called the coffin bone or P3) and the hoof wall, lose blood flow and deteriorate 
(Hood, 1993). These laminae act as Velcro attaching the bone to the hoof wall and without their 
support the bone begins to rotate downward, applying pressure to the sole of the foot and 
crushing the underlying structures, resulting in severe pain.  
 
Laminitis typically progresses through three phases. The first is the developmental phase at 
which no clinical signs are present, making it impossible to begin treatment. Signs such as foot 
pain and increased digital pulse occur during the onset of the second stage, known as acute 
laminitis. This typically begins around 24 to 48 hours after a trigger event and usually lasts 
several days. The third and often irreversible phase is called chronic laminitis. In this phase, 
lamellar damage has become so great that the coffin bone shifts downward (Figure 1.), (Pollitt, 
2002). Treatments such as NSAID pain relievers and cryotherapy can prevent or lessen the 
degree of laminitis if begun in the developmental phase before symptoms occur (Van Epps, 
2004); however, once horses enter the acute stage there is little effective treatment for this 
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disease. Therefore if a diagnostic marker could be identified for the developmental stage, 
veterinarians could begin treatment early enough to ameliorate the pain and tissue damage 
caused by laminitis. 
 
 
 
Figure 1. Rotation of the proximal phalanx.  
Radiographs of a normal front foot (left) compared to a laminitic front foot (right). The normal 
foot radiograph shows the wall of the proximal phalanx (coffin bone) at an angle parallel to the 
hoof wall, while the coffin bone of the laminitic foot has rotated downward (Thompson, 2011). 
 
 
 
 
Laminitis and Citrulline 
Laminitis onset is often triggered by unrelated events occurring elsewhere in the body, such as 
gastrointestinal (GI) system upset episodes (De La Rebière de Pouyade, 2009). Although the 
mechanism linking the GI tract to the foot is unknown, there is evidence that intestinal epithelial 
cell death allows the escape of bacteria into the bloodstream, and those bacterial proteins or 
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immune system factors travel to the foot where they trigger laminitis (Kyaw-Tanner, 2001). 
Interestingly, the health of the intestinal epithelium can be measured using plasma citrulline 
concentrations (Crenn, 2008). Citrulline is an α-amino acid circulated in the plasma of most 
mammals and is produced mainly by intestinal epithelial cells. Studies in humans have shown 
reduced plasma citrulline concentrations in individuals with short bowel syndrome, villous 
atrophy, and Crohn's disease; all of which involve malabsorption and dysfunction of segments of 
bowel (Crenn, 2000). This particular study concluded that reduced plasma citrulline levels are an 
innovative and quantitative biomarker of intestinal epithelial cell death and loss of intestinal 
barrier function and can be used to predict the health and function of the intestine.  
 
Although there are currently no published data regarding citrulline levels in horses with acute 
gastrointestinal diseases, our laboratory has recently found significantly decreased plasma levels 
of citrulline in horses during the developmental stage of experimentally-induced laminitis, 
suggesting that citrulline could also function as a biomarker to predict the onset of symptomatic 
laminitis.  
 
Citrulline has been long identified as an intermediate in the urea cycle (Cox, 2000), and is mainly 
produced by enterocytes of the small intestine in humans (Crenn, 2008). No previous study 
clearly identifies the location in the equine GI tract at which citrulline is produced, however. 
Because colic and other GI diseases can effect one or multiple locations in the equine GI tract, 
localizing the origin of citrulline production will be beneficial to the validity and rationale of the 
study. For example, if citrulline is only produced in the small intestine, an explanation will be 
needed as to how a large colon impaction can potentially effect citrulline production. 
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Potential Outcomes and Study Objectives 
If citrulline is indeed prognostic for the onset of acute laminitis, a simple and affordable blood 
test could be developed to predict a horse’s chance of developing the disease before it progresses 
too far to treat. This would allow earlier and more effective treatment to significantly reduce the 
chance of the horse developing the condition, greatly improving their prognosis. This study will 
also contribute to our understanding of the interaction between intestinal epithelial cell function 
and laminitis. Another possible outcome is the use of citrulline as a less invasive and more 
effective diagnostic indicator of intestinal death during colic than currently used methods. 
 
Two currently used indicators of intestinal damage in humans are serum IgA (DeMeo, 2002), and 
D-Lactate (Murray, 1994). These tests measure intestinal health by analyzing the presence of 
bacterial by-products and immune factors present in the animal’s blood. High levels indicate 
intestinal barrier function is compromised, thus allowing the escape of microorganisms and by-
products into the animal’s bloodstream. Blood and abdominal fluid lactate concentrations are 
also used in horses as an indicator of intestinal damage and surgical prognosis (Van Den Boom, 
2010). The performance of citrulline as both an indicator of GI health as well as a predictor of 
laminitis onset must be comparable or greater than that of currently used tests to prove useful. 
 
In this study we therefore examined citrulline levels in a clinical population of horses at risk of 
laminitis development. Citrulline concentrations were compared between healthy horses, horses 
at risk of laminitis that did not develop laminitis, and horses at risk of laminitis that did develop 
laminitis. We also measured plasma IgA and D-lactate concentrations and compared the 
effectiveness of these tests to that of citrulline in regards to the ability to predict laminitis onset. 
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In order to determine the location of citrulline synthesis, we also analyzed tissues from different 
locations in the equine GI tract for presence of citrulline synthesis enzymes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
CHAPTER II 
 
METHODS 
 
 
 
Sample Collection 
 
Blood samples were collected from client animals at two local veterinary clinics as detailed in 
Animal Use Protocol 2012-115. Briefly, 10 mL of blood was collected from the jugular vein into 
a Vacutainer™ heparin tube by either a licensed veterinarian or a veterinary technician. Blood 
was sampled from healthy control horses (n=23) and horses at risk of laminitis (n=20). Blood 
samples were stored at 4°C from time of collection until centrifugation. Samples were 
centrifuged for 5 minutes at 2000 g to separate the red and white blood cells from the plasma, 
which was then stored in 500 μl aliquots at -20°C until analysis.  
 
The veterinarians assisting with this study were encouraged to use their professional knowledge 
of the disease to choose cases which they felt were at risk of developing laminitis based on 
hospital admission for the GI condition being treated, such as severe colic, diarrhea, or grain 
overload. The veterinary clinic or horse owner was contacted 3 to 5 days post blood collection to 
determine if the horse developed signs of laminitis or other adverse clinical outcomes. 
 
Citrulline Assay and Statistical Analysis 
Plasma amino acid concentrations were analyzed using a chromatography-based amino acid 
analysis by the TAMU Protein Chemistry Laboratory. This method uses automated precolumn 
derivatization of amino acids from plasma with o-phthalaldehyde and reversed-phase 
chromatography for separation of the derivatives. Fluorescence detection is used to measure 
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quantification of amino acids (Teerlink, 1994). Citrulline levels are presented as a percentage of 
total amino acids detected in each sample in order to normalize for inter-individual variation in 
the total concentration of amino acids. The mean citrulline concentration and 95% confidence 
interval of the control group was calculated based on the percent composition citrulline and used 
to determine the normal range of plasma citrulline. 
 
The GI disease group of horses was further divided into two subgroups consisting of horses that 
experienced adverse outcomes including laminitis or death, and horses that did not. The percent 
citrulline composition of the two test groups were compared to the normal citrulline range 
derived from the control group. An ANOVA was used to compare citrulline levels in control 
horses, those that did not develop laminitis, and those that did develop laminitis. The ANOVA 
was also performed for all amino acids detected in the amino acid analysis to allow us to 
recognize changes between the three groups of horses for each amino acid. 
 
Localization of Citrulline Production 
Archived equine tissue samples from the stomach, small intestine, cecum, and large intestine, 
were used to identify the location in the digestive system at which citrulline is produced. RNA 
was extracted from each of the tissue samples with Qiazol cell lysis buffer followed by RNA 
cleanup (RNeasy RNA Isolation Kit, Qiagen) and then reverse transcribed to cDNA (Superscript 
VILO cDNA Synthesis Kit, Invitrogen). Polymerase chain reaction (PCR) primers were designed 
using the equine nucleotide sequences obtained from the NCBI database for carbamoyl 
phosphate synthetase 1 (CPS1), N-acetylglutamate synthase (NAGS), and ornithine 
transcarbamylase (OTC), which collaboratively produce citrulline (Figure 2.). cDNA from tissue 
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samples was paired with nucleotide sequences from each enzyme and amplified using PCR. Each 
reaction consisted of 0.1 μl dTTP, 100 mM Solution (BP2564-1D Fischer Scientific); 1 μl 10 X 
PCR Buffer (P2192-1VL SIGMA Life Science); 0.25 μl REDTaq DNA Polymerase (D5684-
1KU SIGMA Life Science); 0.3 μl each forward and reverse primer stock (10 M); 7.05 μl 
double-distilled H2O; and 25 ng cDNA sample. The PCRs were performed in a thermocycler 
machine which initially incubated the reactions at 95°C for one minute, then proceeded to cycle 
through the following temperatures 31 times, holding the reactions at each temperature for 30 
seconds; 94°C, 58°C, 72°C. After completion of the final cycle the reactions were incubated at 
72°C for five minutes. PCR products were then separated by agarose gel electrophoresis to 
visualize the expression of these enzymes in each of the digestive tract locations.  
 
 
 
 
Figure 2. Horse enzymatic citrulline synthesis pathway.  
Figure 2. illustrates the need for the enzymes NAGS, CPS, and OTC, to synthesize citrulline. 
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IgA and D-Lactate 
Two other methods of assessing GI tract damage commonly used in humans are the analysis of 
plasma IgA and D-Lactate. Both of these tests were performed on plasma samples as a 
comparison to citrulline for effectiveness in differentiating between the three groups of horses: 
control, GI disease with adverse outcome, and GI disease without adverse outcomes. 
 
 IgA was analyzed using an ELISA. For the ELISA, Horse IgA antibody unconjugated (Bethyl 
Laboratories) was diluted 1:100 with PBS coating buffer and 100 μl was added to each well of a 
96 well flat bottom culture plate and incubated overnight at 4 ̊ C. Wells were then washed 5 times 
using PBST wash buffer. Wells were blocked using 300 μl Superblock (Thermo-Pierce) per well, 
then washed 5 more times using PBST. Next, samples were diluted 1:4000 with 10% Superblock 
PBS assay buffer, and a standard curve was prepared with doubling dilutions of reference serum 
(1.5 mg/ml IgA, Bethyl Laboratories) from 1:250 to 1:16,000. Samples, standards, and controls 
were added at 100 μl per well in duplicate and incubated for 90 minutes at 37 ̊ C, then washed 5 
times with PBST. One hundred microliters of Horse IgA antibody (HRP conjugated, Bethyl 
Laboratories) was added to wells at a dilution of 1:150,000 and the plate was incubated for two 
hours at room temperature and then washed 7 times with PBST. Next, SIGMAFAST OPD tablets 
(SIGMA Life Science) were dissolved in 20 ml water and added to the wells at 200 μl per well, 
then incubated for 30 minutes in the dark. Finally, 50 μl 3M HCl was added to stop the reaction 
and the plate was read at 492 nm using a microplate reader.  
 
D-Lactate was measured using a D-Lactate Assay Kit (Abcam) according to the manufacturer’s 
protocol and the absorbance was measured at 450 nm using a microplate reader. 
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Approval 
All animal procedures were approved by the Institutional Animal Care and Use Committee as 
well as the Texas A&M University College of Veterinary Medicine’s Clinical Research Review 
Committee (AUP 2012-115). 
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CHAPTER III 
 
RESULTS 
 
 
 
Clinical Outcome  
All 23 control horses were healthy at the time of blood collection. Of the 19 horses presenting 
with acute GI disease or other condition known to trigger laminitis onset, six developed adverse 
outcomes within 72 hours after blood collection. Five developed symptoms of laminitis and one 
was euthanized prior to the time symptoms would be observed. Of these six, one was diagnosed 
with abortion and colic, three were diagnosed with colitis, one with colic, and one with 
pneumonia and lipemia. Of the 13 horses that recovered successfully, seven were diagnosed with 
routine, non-surgical colic, two were diagnosed with colitis, and three were diagnosed with slight 
grain overload. One of the horses was diagnosed with acute unilateral laminitis with no known 
trigger event.  
 
Citrulline Concentrations  
The mean amino acid percent composition from the control group was 4.29% citrulline with a 
standard deviation of 1.01%, giving a 95% confidence interval of 2.27% to 6.31%, (Figure 3.). 
The mean percent composition citrulline from the six cases resulting in laminitis symptoms or 
death was 1.69% with values ranging from 0.29% to 2.22% leaving the mean and all samples 
outside the 95% confidence interval. The mean percent composition citrulline from the 13 cases 
not resulting in laminitis or death was 3.07%, with values ranging from 1.19% to 5.28% 
citrulline. Six horses from this group also fell below the normal range for citrulline 
concentrations. All horses clinically diagnosed with colitis exhibited citrulline concentrations 
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below the normal range. Horses with GI symptoms that included severe diarrhea also fell below 
the normal range of citrulline concentrations. Among the control horses, no correlation was 
found between breed, age, or sex with regards to citrulline concentration. 
 
 
 
  
 
 
Figure 3. Plasma citrulline in a clinical population of horses.  
Mean plasma concentrations of citrulline normalized to total free amino acid content are shown 
for healthy controls (CON), horses with colic (SICK), and horses with colic that went on to 
develop laminitis (LMN). Horizontal bars represent the mean ± SEM. 
 
 
 
Expression of Citrulline Synthesis Enzymes in Equine GI Tract 
PCR performed on tissue samples from different locations of the equine digestive tract indicated 
that the enzyme OTC is highly expressed throughout the GI tract (Figure 4.). The enzyme NAGS 
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was found to be highly expressed in the small intestine and expressed to a lesser degree in the 
stomach, large intestine, and cecum. The enzyme CPS-1 was exclusively expressed in the small 
intestine. Because citrulline synthesis requires all three enzymes (Cox, 2000), this data indicates 
citrulline is primarily synthesized in the small intestine.  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Electrophoresis gel visualization of PCR products.  
This figure indicates the expression of the three citrulline synthesis enzymes in tissue samples 
from four different locations of the GI tract.  White bands show the expression of the indicated 
enzyme at the corresponding location of the GI tract. 
 
 
Concentrations of Other Amino Acids  
Citrulline performed better than any other amino acid detected at differentiating the horses into 
the groups: control (CON), GI upset with no laminitis (SICK), and GI upset with laminitis 
(LMN). Trends were noticeable via ANOVA, however, among the amino acids serine, glycine, 
alanine, phenylalanine, valine, leucine, and proline, in addition to citrulline (Table 1.). Serine, 
alanine, and leucine concentrations were elevated among the SICK and LMN horses, glycine 
concentrations were elevated in the LMN group only, citrulline concentrations were decreased 
among SICK and LMN horses, valine and phenylalanine concentrations rose only in the SICK 
group, and proline concentrations were found to be decreased in the LMN horses only. 
L     1   2   3   4      L 
OTC 
L - Ladder 
1 - Stomach 
2 - Small intestine 
3 - Large intestine 
4 - Cecum 
L      1   2   3   4      L  L   1   2  3   4       L 
CPS-1 NAGS  
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  CON SICK LMN 
ASP 0.54 ± 0.30 
a
 0.68 ± 0.44
 a
 0.49 ± 0.32
 a
 
GLU 2.85 ± 1.21
a
 4.09 ± 2.66
 a
 2.83 ± 0.96
 a
 
ASN 1.91 ±1.18
 a
 1.03 ± 0.43
 a
 1.05 ± 0.64
 a
 
SER 9.38 ± 2.25
 a
 6.65 ± 1.76 
b
 6.38 ± 2.10
 b
 
GLN 14.67 ± 2.50
 a
 14.71 ± 4.41
 a
 14.50 ± 3.84
 a
 
HIS 3.35 ± 0.61
 a
 3.71 ± 0.64
 a
 3.14 ± 0.73
 a
 
GLY 19.22 ± 2.83
 a
 17.84 ± 3.89
 a
 21.92 ± 3.93
 b
 
THR 4.00 ± 1.13
 a
 3.92 ± 1.05
 a
 3.34 ± 0.75
 a
 
CIT 4.48 ± 1.17
 a
 3.02 ± 1.65
 b
 1.60 ± 1.21
 b
 
ALA 7.39 ± 2.13
 a
 9.93 ± 2.69
 b
 11.78 ± 4.11
 b
 
ARG 4.64 ± 1.56
 a
 3.53 ± 1.79
 a
 3.63 ± 2.41
 a
 
TYR 2.35 ± 0.47
 a
 2.29 ± 0.41
 a
 1.94 ± 0.38
 a
 
VAL 7.22 ± 0.87
 a
 8.72 ± 1.37
 b
 8.50 ± 2.96
 a
 
MET 1.55 ± 0.45
 a
 1.45 ± 0.30
 a
 1.26 ± 0.33
 a
 
PHE 2.54 ± 0.41
 a
 3.36 ± 0.95
 b
 2.84 ± 0.51
 a
 
ILE 2.37 ± 0.33
 a
 2.54 ± 0.73
 a
 2.48 ± 1.07
 a
 
LEU 4.47 ± 0.62
 a
 5.76 ± 0.88
 b
 5.72 ± 1.60
 b
 
LYS 3.22 ± 0.64
 a
 3.21 ± 1.19
 a
 3.61 ± 1.52
 a
 
PRO 3.87 ± 0.88
 a
 3.56 ± 0.83
 a
 2.98 ± 0.43
 b
 
1
 Means within a row without a common letter differ, P < 0.05 
Table 1. Amino acid ANOVA results. 
Plasma amino acid concentrations, presented as percent of total free amino acids in clinically 
normal horses (CON, n = 23), horses with colic or sepsis (SICK, n = 13), and horses with colic 
or sepsis that experienced adverse outcomes, including laminitis or death (LMN, n = 6)
1
. 
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IgA  
The mean plasma concentration of IgA for the control group was 0.999 mg/ml with a standard 
deviation of 0.622 producing a 95% confidence interval range of -0.245 to 2.243 mg/ml. No 
CON horses had IgA concentrations outside the normal range, two SICK horses fell outside the 
normal range, and the one horse from the LMN group which was euthanized fell outside the 
normal range. All horses with concentrations outside the normal range had elevated IgA 
concentrations. The mean IgA concentration of the SICK group was 1.305 mg/ml and the mean 
of the LMN group was 1.291 mg/ml, both lying inside the 95% confidence interval (Figures 5 
and 6.). The ANOVA test also did not detect differences in IgA concentrations between the three 
groups of horses. 
 
D-Lactate  
The mean plasma concentration of D-lactate for the control group was 0.021 mM with a standard 
deviation of 0.052 producing a 95% confidence interval range of -0.084 to 0.125 mM. One CON 
horse had D-lactate concentrations outside the normal range, two SICK horses fell outside the 
normal range, and two LMN horses fell outside the normal range. All horses with concentrations 
outside the normal range had increased D-lactate concentrations. The mean D-lactate 
concentration of the SICK group was 0.079 mM and the mean of the LMN group was 0.092 mM, 
both inside the 95% confidence range. The ANOVA test also did not show differences in D-
lactate concentrations between the three groups of horses. 
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Figures 5 and 6. Plasma D-lactate and IgA concentrations among three groups of horses. 
Mean D-lactate (bottom) and IgA (top) concentrations are shown for healthy control horses 
(CON), horses with colic (SICK), and horses with colic that proceeded to develop laminitis 
(LMN). Horizontal bars represent the mean ± SEM. 
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CHAPTER IV 
 
CONCLUSIONS 
 
 
 
Discussion 
Because our results showed that all horses that developed laminitis also had plasma citrulline 
concentrations less than two standard deviations below the mean for normal horses, a future test 
would most likely give a ‘positive’ reading for all colicing horses that would proceed to develop 
laminitis. This test would most likely also give a ‘positive’ reading for some horses that would 
not develop laminitis, since 40% of horses from this study which did not develop laminitis had 
low citrulline levels. We can therefore conclude that a potential citrulline test would be highly 
sensitive, but have low specificity. This type of test would still be useful for identifying all 
horses at high risk of laminitis development during a colic or other GI upset episode. Fortunately 
cryotherapy is an effective preventative measure for laminitis during the developmental phase 
that is not costly or harmful to horses, therefore treating all horses that tested ‘positive’ would 
not cause negative outcomes (Van Epps, 2004).  
 
Our data suggests that citrulline performed better at discriminating between the three groups of 
horses than IgA or D-lactate. Because the mean concentrations of both IgA and D-lactate for the 
different groups of horses do not fall outside the confidence interval for the normal range and  
did not fall into different groupings via ANOVA, IgA and D-lactate do not predict adverse 
outcomes as well as citrulline does in horses.  
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Immunologic responses act as one of many protective mechanisms to the gastrointestinal system. 
In humans, IgA is the primary antibody secreted into the gut and acts to bind foreign antigens 
(DeMeo, 2002). Therefore increased concentrations of IgA can signify bacterial infection and 
loss of intestinal barrier function (DeMeo, 2002). D-lactate is a byproduct of bacterial 
metabolism and is also used in humans as an indicator for many gastrointestinal diseases 
(Murray, 1994). Increased D-lactate concentrations in humans indicate bacterial infection or loss 
of intestinal barrier function (Smith, 1986). Because our results did not show significant changes 
in IgA or D-lactate among the three groups of horses, these findings contrast the results of IgA 
and D-lactate in humans. This could result from the numerous differences between the GI 
systems of humans and horses such as diet, location of bacterial fermentation, bacterial flora, and 
many anatomical and physiological differences (Dyce, 2010) . 
  
Similar biomarkers such as lactate concentrations are commonly and accurately used in horses to 
identify sepsis and measure intestinal health (Van Den Boom, 2010). The most common cause of 
hyperlactaemia is hypervolemia and the resulting decrease in tissue perfusion. Lactate 
concentrations can therefore be measured and compared between the blood and the abdominal 
fluid. An abdominal fluid lactate concentration higher than that of the blood lactate concentration 
is considered evidence of intestinal strangulation and sepsis (Moore, 1976). There is no 
published data regarding the use of lactate as an indicator of laminitis, and there are not any 
commercially available tests capable of predicting laminitis onset or published studies regarding 
potential biomarkers for laminitis.  
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Concentrations of amino acids have been studied as an indicator of sepsis in humans, and these 
findings differ from the data of our three groups of horses (Freund, 1979). All the aromatic and 
sulfur containing amino acids were found to increase during sepsis in humans, while only 
phenylalanine from this group was found to be elevated in our data from GI upset horses. Valine, 
leucine, arginine, and isoleucine were found to decrease during sepsis in humans. Our data 
showed increased concentrations of valine and leucine, and normal concentrations for arginine 
and isoleucine in GI upset horses. Also, serine, alanine, glycine, and proline were found to 
remain normal in humans, yet showed changes among the different groups of horses in our data.  
 
Our PCR results showed the expression of all three citrulline synthesis enzymes only in the small 
intestine, concluding the location of citrulline synthesis in the GI tract. This would imply that all 
cases resulting in decreased citrulline levels must have suffered a compromised small intestine. 
Interestingly, many of the horses displaying decreased citrulline levels presented with colitis or 
large colon or cecal impactions/displacements, rather than small intestinal issues. A possible 
explanation for this could be that due to the hindgut blockage; the small intestine was 
secondarily compromised, thus decreasing its citrulline production. There does not appear to be 
published data regarding the effects of hindgut colic or colitis on the small intestine, however 
small intestinal motility and barrier function decreases during diarrhea, and small intestinal blood 
flow and barrier function decreases during endotoxemia (Clark, 1990). Because all of the horses 
suffering diarrhea and endotoxemia due to severe colic or colitis in our study had reduced 
citrulline levels, we can suggest the decrease resulted from small colon loss of functionality 
resulting from these events. 
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Clinical Implications 
If further studies conclude that citrulline levels correlate with laminitis onset across a large set of 
samples, a commercially available blood test could be developed in the future to identify horses 
at high risk of developing laminitis before it progresses too far to treat. Veterinarians could then 
begin treatments on horses at high risk of laminitis to reduce the chance of the horse developing 
the condition and greatly improve their prognosis. Further studies will also contribute to our 
understanding of the interaction between intestinal epithelial cell function and laminitis. Because 
citrulline levels were reduced in the most severe GI upset cases including diarrhea, colitis, 
endotoxemia, and displacement, another possible outcome of this study is the use of citrulline as 
a less invasive diagnostic indicator of intestinal death during colic than the currently used 
abdominocentesis procedure for obtaining abdominal fluid. 
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